Showing results (701-710 of 2,331) with videos related to
Sort By:
Pageof 234
Clinical Drug Investigation|August 14, 2021
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2-3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre ExperienceGiammarco Milella, Alessandro Introna, Eustachio D'Errico, et al.Clinical Drug Investigation|June 20, 2020
Association Between an Acute, Drug-Induced Decrease in High-Density Lipoprotein Cholesterol Levels and Risk of Cardiovascular EventsGema Requena, Liyuan Ma, Til Stürmer, et al.Clinical Drug Investigation|August 17, 2022
Clinical Characteristics and Implications of Bradycardia in COVID-19 Patients Treated with Remdesivir: A Single-Center Retrospective Cohort StudyAriyon Schreiber, Justin S Bauzon, Kavita Batra, et al.Clinical Drug Investigation|November 19, 2021
Comparing Sacubitril/Valsartan Against Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure: A Systematic Review and Network Meta-analysisYao Neng Teo, Yao Hao Teo, Nicholas L Syn, et al.Clinical Drug Investigation|November 27, 2021
Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed ConditionsNan-Nan Chu, Lin Zhang, Jiakun Wang, et al.Clinical Drug Investigation|September 17, 2022
Budget Impact Analysis of the Introduction of a Trastuzumab Biosimilar for HER2-Positive Breast Cancer in ChinaQingqing Chai, Haini Wen, Yitian Lang, et al.Clinical Drug Investigation|March 9, 2021
Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side EffectsCarla Rognoni, Arianna Bertolani, Claudio JommiClinical Drug Investigation|November 4, 2022
Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsDevarapalli Ranjani Durga, Nadella Mounika, Pravallika Mudimala, et al.Clinical Drug Investigation|October 14, 2022
Effect of Food on the Pharmacokinetics of Senaparib (IMP4297) in Healthy Chinese SubjectsXianmin Meng, Xiaoyan Lin, Rongrong Jiang, et al.Clinical Drug Investigation|October 31, 2022
Cost-Utility Analysis Comparing Direct Oral Anticoagulant and Low Molecular Weight Heparin Therapies for Secondary Prevention of Cancer-Associated ThrombosisYoung Eun Shin, Arun Kumar, Monica Hwang, et al.Pageof 234